<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ870318-0147 </DOCNO><HL> Genetics Institute Inc.                                                  </HL><DD> 03/18/87</DD><SO>  </SO><IN> HENG GENITENDER OFFERS, MERGERS, ACQUISITIONS (TNM) </IN><DATELINE> CAMBRIDGE, Mass. </DATELINE><TEXT>   Genetics Institute Inc. said that as part of its effort to expand and improve its production facilities, it bought a plant and property from a division of Fisher Scientific Group for $15.3 million.    Fisher Scientific is a unit of Henley Group Inc., La Jolla, Calif.    The company plans to invest an additional $20 million to equip the facility for process-development activities and clinical-scale production. Genetics Institute said it will move all of its process-development, pilot and clinical production groups from its headquarters here to the Andover, Mass., facility.    The company said the new plant will enable it to meet certain testing requirements for its products to receive government approval.    Genetics Institute develops human pharmaceutical and diagnostic products using recombinant DNA and related technologies. Activities at the 50-acre site will relate to cell culture, microbial fermentation, process biochemistry and other areas.    In national over-the-counter trading yesterday, Genetics Institute shares closed at $37.25, up $2.75. </TEXT></DOC>